<DOC>
	<DOCNO>NCT00765011</DOCNO>
	<brief_summary>A Phase II Trial With Radiotherapy Plus Cetuximab Evaluate Specific Survival Free Laryngectomy Patients With Resectable Locally Advanced Larynx Cancer , After Treatment With TPF Chemotherapy .</brief_summary>
	<brief_title>TPF Plus Radiotherapy Cetuximab Avoid Total Laryngectomy Patients With Larynx Cancer</brief_title>
	<detailed_description>This study sponsor cooperative medical group .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>1 . Signed Informed Consent Form . 2 . Men woman , age ( 18 70 ) . 3 . ECOG scale:01 . 4 . Life expectancy superior 3 month . 5 . Larynx squamous carcinoma histologically demonstrate . 6 . Patients larynx squamous carcinoma , stage IIIIVA , resectable disease whose surgery imply total laryngectomy . The T T3 , T4A , T2 candidate partial laryngectomy . In case T2 location require III IVA stadium . 7 . Patients able receive treatment TPF follow normofractionated radiotherapy cetuximab . 8 . Measurable disease ( OMS criterion ) . 9 . Neutrophils superior equal 1500/mm3 , platelet superior equal 150.000/mm3 , hemoglobin superior equal 10 g/dl . 10 . Adequate renal function : creatinin lower equal 120 Âµmol/l ( 1,4mg/dl ) 11 . Adequate hepatic function : bilirubin lower equal 1 x UNL , AST ALT low equal 2,5 UNL , alkaline phosphatase lower equal 5 UNL . 12 . Seric calcium adjust albumine low equal 1,25 UNL . 13 . Adequate nutritional condition : loss weight &lt; 20 % relation theoretical weight albumin superior equal 35 g/L . 14 . Use effective contraceptive method . 1 . Metastatic disease 2 . Surgical treatment , previous radiotherapy and/or chemotherapy study disease . 3 . Other tumour location H &amp; N larynx . 4 . Other stage III IVa without metastasis resectable disease . 5 . The following case , consider candidate radical surgery , include study : Tumors subglottis . Tumors glottis supraglottis subglottal extension Tumor destroy thyroid cartilage and/or cricoid extend thyroid gland soft neck 's tissue . Tumor supraglottis superior extension 1 cm towards tongue base ( extension measure since vallecula ) . 6 . Other previous and/or synchronic squamous carcinoma . 7 . Diagnosis another neoplasia last 5 year , except carcinoma situ uterine neck and/or cutaneous carcinoma basocellular properly treat . 8 . Active infection ( need endovenous antibiotic ) , include active tuberculosis diagnose HIV . 9 . Not control hypertension define arterial systolic tension superior equal 180 mm Hg and/or diastolic arterial tension superior equal 130 mm Hg baseline . 10 . Pregnancy breastfeed . 11 . Immunity systemic treatment , chronic concomitant , hormonal treatment cancer . 12 . Other antineoplasic concomitant treatment . 13 . Coronary clinically significant arteriopathy precedent myocardial infarction last 12 month high risk control arrhythmia cardiac control insufficiency . 14 . Pulmonary obstructive chronic disease need 3 hospitalization last 12 month . 15 . Active non control peptic ulcer . 16 . Presence psychological medical disease could prevent accomplish study patient grant his/her signature inform consent form . 17 . Known drug abuse ( except excessive consumption alcohol ) . 18 . Known allergic reaction component treatment study . 19 . Previous treatment monoclonal antibody transduction sign inhibitor treatment direct EGFR . 20 . Any experimental treatment 30 day entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Head Neck Cancer</keyword>
</DOC>